Comoros
Tuberculosis profile
Population  2013 <1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.058 (0.035–0.087) 7.8 (4.8–12)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.45 (0.21–0.8) 62 (28–108)
Incidence  (includes HIV+TB) 0.25 (0.21–0.3) 34 (28–41)
Incidence (HIV+TB only)        
Case detection, all forms (%) 48 (40–59)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.9 (0.1–5.3) 20 (0.1–40)
MDR-TB cases among notified pulmonary
TB cases
2 (0–5) 1 (0–1)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 67   3
Pulmonary, clinically diagnosed 19   0
Extrapulmonary 32   0
       
Total new and relapse 121    
Previously treated, excluding relapses 0    
Total cases notified 121    
Among 70 new and relapse cases:
0 (0%) cases aged under 15 years; male:female ratio: 2.0
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 0 (0%) 0 (0%) 0
Laboratory-confirmed RR-/MDR-TB cases     0
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 129 (107)
HIV-positive TB patients 4 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 4 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 4 (100)
HIV-positive people screened for TB 4  
HIV-positive people provided with IPT 4  
Treatment success rate (%)
New and relapse cases registered in 2012 87
Previously treated cases, excluding relapse, registered in 2012  
HIV-positive TB cases, all types, registered in 2012 25
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? No
Financing TB control 2014  
National TB programme budget (US$ millions) <1
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-03-05 Data: www.who.int/tb/data